VBI Vaccines Inc

NASDAQ: VBIV
$0.59
-$0.02 (-3.0%)
Closing price April 24, 2024
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company is headquartered in Cambridge, Massachusetts.

Markets Pump the Brakes After Thursday Rally: Analysts Upgrade or Downgrade Intel, Occidental, Roku and More
Friday’s additional top analyst upgrades and downgrades were on Freeport-McMoRan, GSK, Intel, L3Harris Technologies, Occidental Petroleum, Roku, Six Flags Entertainment, Spirit AeroSystems, Sprouts...
Chris Lange
Published:

Wednesday Afternoon's Analyst Upgrades and Downgrades: Inovio Pharmaceuticals, McDonald's, VBI Vaccines, Wingstop and More
Wednesday afternoon's top analyst upgrades and downgrades included Inovio Pharmaceuticals, McDonald’s, Orchard Therapeutics, VBI Vaccines and Wingstop.
Chris Lange
Published: